
The global Iodixanol API market size is predicted to grow from US$ 331 million in 2025 to US$ 433 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
The market for Iodixanol API is driven by its application in radiology and diagnostic imaging. Iodixanol provides high-quality and clear imaging results, making it valuable in various medical procedures. The demand for effective and safe contrast agents contributes to the growth of this market.
The “Iodixanol API Industry Forecast” looks at past sales and reviews total world Iodixanol API sales in 2024, providing a comprehensive analysis by region and market sector of projected Iodixanol API sales for 2025 through 2031. With Iodixanol API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodixanol API industry.
This Insight Report provides a comprehensive analysis of the global Iodixanol API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iodixanol API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iodixanol API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodixanol API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodixanol API.
This report presents a comprehensive overview, market shares, and growth opportunities of Iodixanol API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Original Drug
Generic Drug
Segmentation by Application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Hengrui Medicine
Daiichi Sankyo
YRPG
BeiLu Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Iodixanol API market?
What factors are driving Iodixanol API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iodixanol API market opportunities vary by end market size?
How does Iodixanol API break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iodixanol API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Iodixanol API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Iodixanol API by Country/Region, 2020, 2024 & 2031
2.2 Iodixanol API Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Iodixanol API Sales by Type
2.3.1 Global Iodixanol API Sales Market Share by Type (2020-2025)
2.3.2 Global Iodixanol API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Iodixanol API Sale Price by Type (2020-2025)
2.4 Iodixanol API Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Iodixanol API Sales by Application
2.5.1 Global Iodixanol API Sale Market Share by Application (2020-2025)
2.5.2 Global Iodixanol API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Iodixanol API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Iodixanol API Breakdown Data by Company
3.1.1 Global Iodixanol API Annual Sales by Company (2020-2025)
3.1.2 Global Iodixanol API Sales Market Share by Company (2020-2025)
3.2 Global Iodixanol API Annual Revenue by Company (2020-2025)
3.2.1 Global Iodixanol API Revenue by Company (2020-2025)
3.2.2 Global Iodixanol API Revenue Market Share by Company (2020-2025)
3.3 Global Iodixanol API Sale Price by Company
3.4 Key Manufacturers Iodixanol API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iodixanol API Product Location Distribution
3.4.2 Players Iodixanol API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Iodixanol API by Geographic Region
4.1 World Historic Iodixanol API Market Size by Geographic Region (2020-2025)
4.1.1 Global Iodixanol API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Iodixanol API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Iodixanol API Market Size by Country/Region (2020-2025)
4.2.1 Global Iodixanol API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Iodixanol API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Iodixanol API Sales Growth
4.4 APAC Iodixanol API Sales Growth
4.5 Europe Iodixanol API Sales Growth
4.6 Middle East & Africa Iodixanol API Sales Growth
5 Americas
5.1 Americas Iodixanol API Sales by Country
5.1.1 Americas Iodixanol API Sales by Country (2020-2025)
5.1.2 Americas Iodixanol API Revenue by Country (2020-2025)
5.2 Americas Iodixanol API Sales by Type (2020-2025)
5.3 Americas Iodixanol API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iodixanol API Sales by Region
6.1.1 APAC Iodixanol API Sales by Region (2020-2025)
6.1.2 APAC Iodixanol API Revenue by Region (2020-2025)
6.2 APAC Iodixanol API Sales by Type (2020-2025)
6.3 APAC Iodixanol API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Iodixanol API by Country
7.1.1 Europe Iodixanol API Sales by Country (2020-2025)
7.1.2 Europe Iodixanol API Revenue by Country (2020-2025)
7.2 Europe Iodixanol API Sales by Type (2020-2025)
7.3 Europe Iodixanol API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Iodixanol API by Country
8.1.1 Middle East & Africa Iodixanol API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Iodixanol API Revenue by Country (2020-2025)
8.2 Middle East & Africa Iodixanol API Sales by Type (2020-2025)
8.3 Middle East & Africa Iodixanol API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iodixanol API
10.3 Manufacturing Process Analysis of Iodixanol API
10.4 Industry Chain Structure of Iodixanol API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iodixanol API Distributors
11.3 Iodixanol API Customer
12 World Forecast Review for Iodixanol API by Geographic Region
12.1 Global Iodixanol API Market Size Forecast by Region
12.1.1 Global Iodixanol API Forecast by Region (2026-2031)
12.1.2 Global Iodixanol API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Iodixanol API Forecast by Type (2026-2031)
12.7 Global Iodixanol API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Iodixanol API Product Portfolios and Specifications
13.1.3 GE Healthcare Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Hengrui Medicine
13.2.1 Hengrui Medicine Company Information
13.2.2 Hengrui Medicine Iodixanol API Product Portfolios and Specifications
13.2.3 Hengrui Medicine Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hengrui Medicine Main Business Overview
13.2.5 Hengrui Medicine Latest Developments
13.3 Daiichi Sankyo
13.3.1 Daiichi Sankyo Company Information
13.3.2 Daiichi Sankyo Iodixanol API Product Portfolios and Specifications
13.3.3 Daiichi Sankyo Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Daiichi Sankyo Main Business Overview
13.3.5 Daiichi Sankyo Latest Developments
13.4 YRPG
13.4.1 YRPG Company Information
13.4.2 YRPG Iodixanol API Product Portfolios and Specifications
13.4.3 YRPG Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 YRPG Main Business Overview
13.4.5 YRPG Latest Developments
13.5 BeiLu Pharma
13.5.1 BeiLu Pharma Company Information
13.5.2 BeiLu Pharma Iodixanol API Product Portfolios and Specifications
13.5.3 BeiLu Pharma Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BeiLu Pharma Main Business Overview
13.5.5 BeiLu Pharma Latest Developments
14 Research Findings and Conclusion
*If Applicable.
